EDGAR Filing Documents for 0001683168-22-000663

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]

SEC Accession No. 0001683168-22-000663

Filing Date

2022-02-03

Accepted

2022-02-03 17:31:13

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	FORM S-1 AMENDMENT 2	sunshine_s1a2.htm iXBRL	S-1/A	1303750
2	CONSENT TO BE NAMED AS A DIRECTOR NOMINEE	sunshine_ex9901.htm	EX-99.1	2424
3	CONSENT TO BE NAMED AS A DIRECTOR NOMINEE	sunshine_ex9902.htm	EX-99.2	2352
4	FILING FEE TABLE	sunshine_ex107.htm	EX-FILING FEES	12668
10	GRAPHIC	image_001.jpg	GRAPHIC	7392
11	GRAPHIC	image_007.jpg	GRAPHIC	11849
12	GRAPHIC	image_008.jpg	GRAPHIC	13466
13	GRAPHIC	image_009.jpg	GRAPHIC	18576
14	GRAPHIC	image_010.jpg	GRAPHIC	9687
	Complete submission text file	0001683168-22-000663.txt		3540357

Data Files

Seq	Description	Document	Type	Size
5	XBRL SCHEMA FILE	sbfm-20210930.xsd	EX-101.SCH	15405
6	XBRL CALCULATION FILE	sbfm-20210930_cal.xml	EX-101.CAL	34965
7	XBRL DEFINITION FILE	sbfm-20210930_def.xml	EX-101.DEF	77105
8	XBRL LABEL FILE	sbfm-20210930_lab.xml	EX-101.LAB	160040
9	XBRL PRESENTATION FILE	sbfm-20210930_pre.xml	EX-101.PRE	130704
33	EXTRACTED XBRL INSTANCE DOCUMENT	sunshine_s1a2_htm.xml	XML	224531

Mailing Address 6500 TRANS-CANADA HIGHWAY 4TH FLOOR POINTE-CLAIRE A8 H9R 0A5

Business Address 6500 TRANS-CANADA HIGHWAY 4TH FLOOR POINTE-CLAIRE A8 H9R 0A5 514-426-6161

Sunshine Biopharma, Inc (Filer) CIK: 0001402328 (see all company filings)